Literature DB >> 14616774

Dendritic cells and the handling of antigen.

F Dieli.   

Abstract

Mesh:

Year:  2003        PMID: 14616774      PMCID: PMC1808858          DOI: 10.1046/j.1365-2249.2003.02279.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  33 in total

Review 1.  Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization.

Authors:  I Kimber; M Cumberbatch; R J Dearman; M Bhushan; C E Griffiths
Journal:  Br J Dermatol       Date:  2000-03       Impact factor: 9.302

Review 2.  Immunobiology of dendritic cells.

Authors:  J Banchereau; F Briere; C Caux; J Davoust; S Lebecque; Y J Liu; B Pulendran; K Palucka
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

3.  Induction of vigorous helper and cytotoxic T cell as well as B cell responses by dendritic cells expressing a modified antigen targeting receptor-mediated internalization pathway.

Authors:  Z You; X F Huang; J Hester; L Rollins; C Rooney; S Y Chen
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

4.  Dendritic cells recruitment and in vivo priming of CD8+ CTL induced by a single topical or transepithelial immunization via the buccal mucosa with measles virus nucleoprotein.

Authors:  N Etchart; P O Desmoulins; K Chemin; C Maliszewski; B Dubois; F Wild; D Kaiserlian
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

Review 5.  Langerhans cell migration.

Authors:  M Cumberbatch; R J Dearman; C E Griffiths; I Kimber
Journal:  Clin Exp Dermatol       Date:  2000-07       Impact factor: 3.470

6.  In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying viral CD8+ T cell epitopes.

Authors:  C Fayolle; P Sebo; D Ladant; A Ullmann; C Leclerc
Journal:  J Immunol       Date:  1996-06-15       Impact factor: 5.422

Review 7.  Mouse and human dendritic cell subtypes.

Authors:  Ken Shortman; Yong-Jun Liu
Journal:  Nat Rev Immunol       Date:  2002-03       Impact factor: 53.106

8.  The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.

Authors:  N Haicheur; E Bismuth; S Bosset; O Adotevi; G Warnier; V Lacabanne; A Regnault; C Desaymard; S Amigorena; P Ricciardi-Castagnoli; B Goud; W H Fridman; L Johannes; E Tartour
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

9.  Langerhans' cells in the murine oral mucosa in the inductive phase of delayed type hypersensitivity with 1-chloro-2, 4-dinitrobenzene.

Authors:  T Okamura; M Morimoto; G Yamane; S Takahashi
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

10.  Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody.

Authors:  G Kraal; M Breel; M Janse; G Bruin
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Next-Generation Vaccines: Nanoparticle-Mediated DNA and mRNA Delivery.

Authors:  William Ho; Mingzhu Gao; Fengqiao Li; Zhongyu Li; Xue-Qing Zhang; Xiaoyang Xu
Journal:  Adv Healthc Mater       Date:  2021-01-18       Impact factor: 11.092

2.  Post-genomic platform for development of oligonucleotide vaccines against RNA viruses: diamond cuts diamond.

Authors:  V V Oberemok; O A Andreeva; K V Laikova; I A Novikov; A V Kubyshkin
Journal:  Inflamm Res       Date:  2022-05-06       Impact factor: 6.986

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.